First Eagle Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-17,686
Closed -$1.33M 255
2017
Q4
$1.33M Buy
17,686
+3,348
+23% +$253K ﹤0.01% 215
2017
Q3
$1.1M Hold
14,338
﹤0.01% 234
2017
Q2
$1.07M Hold
14,338
﹤0.01% 217
2017
Q1
$954K Hold
14,338
﹤0.01% 218
2016
Q4
$936K Hold
14,338
﹤0.01% 220
2016
Q3
$1.01M Hold
14,338
﹤0.01% 241
2016
Q2
$1.06M Hold
14,338
﹤0.01% 247
2016
Q1
$931K Hold
14,338
﹤0.01% 234
2015
Q4
$1.1M Hold
14,338
﹤0.01% 217
2015
Q3
$1.18M Hold
14,338
﹤0.01% 214
2015
Q2
$1.26M Hold
14,338
﹤0.01% 213
2015
Q1
$1.27M Hold
14,338
﹤0.01% 224
2014
Q4
$1.19M Hold
14,338
﹤0.01% 227
2014
Q3
$1.21M Sell
14,338
-237
-2% -$19.2K ﹤0.01% 228
2014
Q2
$1.18M Hold
14,575
﹤0.01% 227
2014
Q1
$1.11M Hold
14,575
﹤0.01% 204
2013
Q4
$1.05M Hold
14,575
﹤0.01% 208
2013
Q3
$1M Hold
14,575
﹤0.01% 217
2013
Q2
$923K Buy
+14,575
New +$948K ﹤0.01% 244

Other funds holding NVS

First Eagle Investment Management's NVS Position: Q1 2018 in Review

First Eagle Investment Management sold out of Novartis (NVS) in Q1 2018, closing a stake of 17,686 shares — an estimated $1.33M sold.

First Eagle Investment Management first reported a position in NVS in Q2 2013 and held it in 19 quarters. The position peaked at $1.33M in Q4 2017. 1,013 funds tracked by Wall St. Rank hold NVS as of Q1 2018.

  • First Eagle Investment Management reported no remaining Novartis position as of Q1 2018 after selling out during the quarter.
  • First Eagle Investment Management sold 17,686 Novartis shares in Q1 2018, an estimated $1.33M.
  • First Eagle Investment Management first reported a position in Novartis in Q2 2013 and held it in 19 quarters.
  • First Eagle Investment Management's Novartis position peaked at $1.33M in Q4 2017.
  • 1,013 funds tracked by Wall St. Rank held Novartis as of Q1 2018.

Based on First Eagle Investment Management's 13F filing for Q1 2018, filed 4 May 2018.